Phibro Animal Health PAHC Animal Health — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phibro Animal Health's animal health — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phibro Animal Health's animal health — revenue?
- Phibro Animal Health (PAHC) reported animal health — revenue of $291.23M in Q1 2026.
- How has Phibro Animal Health's animal health — revenue changed year-over-year?
- Phibro Animal Health's animal health — revenue increased by 12.7% year-over-year, from $258.38M to $291.23M.
- What is the long-term trend for Phibro Animal Health's animal health — revenue?
- Over 4 years (2021 to 2025), Phibro Animal Health's animal health — revenue has grown at a 15.3% compound annual growth rate (CAGR), from $545.72M to $962.8M.
- What does animal health — revenue mean?
- This metric represents the net revenue recognized from the sale of animal health products, such as antibacterials, vaccines, and nutritional specialties, to external customers. It is the core measure of the segment's ability to generate value from its primary business activities. Tracking this metric is essential for evaluating the segment's market share growth and competitive positioning within the animal health industry.